Pharmacy Benefit Management Market Report 2026

The pharmacy benefit management market size has grown strongly in recent years. It will grow from $695.73 billion in 2025 to $755.09 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to rising healthcare expenditure levels, expansion of insured populations, increasing complexity of drug pricing, early adoption of managed pharmacy networks, growth of mail-order pharmacy services.

The pharmacy benefit management market size is expected to see strong growth in the next few years. It will grow to $1.03 trillion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to increasing use of AI-enabled cost optimization tools, rising focus on value-based care models, expansion of specialty drug management, growing regulatory scrutiny on drug pricing, increasing digitalization of pharmacy benefit platforms. Major trends in the forecast period include increasing adoption of data-driven formulary management, rising use of predictive cost analytics, growing integration of digital claims processing platforms, expansion of specialty pharmacy management services, enhanced focus on cost containment strategies.

The rising burden of chronic diseases is expected to drive the growth of the pharmacy benefit management market in the coming years. Chronic diseases are long-term medical conditions that typically last for three months or longer and require ongoing management. Pharmacy benefit management plays a key role in addressing chronic diseases by optimizing medication access, encouraging adherence, and implementing cost-effective strategies that improve health outcomes and quality of life for patients with long-term conditions. For instance, in September 2023, according to the World Health Organization (WHO), a Switzerland-based intergovernmental health organization, noncommunicable diseases accounted for 41 million deaths annually, representing 74% of all global deaths. These included 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2 million from diabetes. Therefore, the increasing prevalence of chronic diseases is contributing to the growth of the pharmacy benefit management market.

Major companies operating in the pharmacy benefit management market are emphasizing innovation through the integration of technology and clinical services, such as medication therapy management solutions. Medication therapy management is a pharmacist-led clinical service focused on reviewing and optimizing a patient’s medication regimen and resolving drug-related issues to improve health outcomes. For example, in May 2025, America’s TPA LLC, a US-based independent health innovator specializing in pharmacy management solutions, launched EZrx, a next-generation pharmacy solution that applies six cost-reduction strategies, including therapeutic substitution and prior authorization. The platform also incorporates advanced analytics and member engagement tools to further enhance pharmacy benefit management efficiency and support improved clinical outcomes.

In March 2025, Northwind Pharmaceuticals, a US-based company focused on prescription drug solutions, partnered with Healthee to strengthen pharmacy benefit management offerings for employers. Through this partnership, Northwind aims to help employers better control prescription drug costs and improve employee access to medications by utilizing Healthee’s digital platform, which simplifies benefit navigation and delivers actionable insights into drug pricing. Healthee is a US-based digital health company specializing in solutions that enhance transparency and engagement within pharmacy benefit management.

Major companies operating in the pharmacy benefit management market are CVS Health Corporation, Cigna Corporation, Centene Corporation, Anthem Inc., OptumRx Inc., Humana Pharmacy Solutions Inc., Magellan Health Inc., Prime Therapeutics LLC, MaxorPlus Ltd., RxAdvance Corp, MedImpact Healthcare Systems Inc., PerformRx LLC., Navitus Health Solutions LLC, WellDyneRx Inc., Healthesystems LLC., Catalyst Rx Inc., Argus Health Systems Inc., Innoviant Pharmacy Inc., Pharmaceutical Strategies Group, ProCare Rx Inc., FutureScripts LLC., National CooperativeRx, ScriptCare Ltd., US Script Inc., LDI Integrated Pharmacy Services LLC, RxPreferred Benefits, SinfoníaRx Inc.

North America was the largest region in the pharmacy benefit management market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacy benefit management market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pharmacy benefit management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the pharmacy benefit management market by increasing costs associated with imported IT infrastructure, data servers, security hardware, and digital transaction platforms supporting claims processing and network management. PBM operators in North America are most affected due to reliance on global technology supply chains, while Asia-Pacific faces cost pressure on outsourced IT services. These tariffs are increasing operational expenses and slowing technology upgrades. However, they are also driving domestic IT investments, localized data infrastructure development, and enhanced focus on cost-efficient digital platforms.

The pharmacy benefit management market research report is one of a series of new reports that provides pharmacy benefit management market statistics, including pharmacy benefit management industry global market size, regional shares, competitors with a pharmacy benefit management market share, detailed pharmacy benefit management market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacy benefit management industry. This pharmacy benefit management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pharmacy benefit management comprises a range of organizations that act as intermediaries between insurance providers, pharmacies, and drug manufacturers. These entities are used to help insurers and health plans reduce prescription drug costs by negotiating pricing and reimbursement terms with pharmacies and pharmaceutical companies.

The primary services offered under pharmacy benefit management include mail-delivery, specialty pharmacy services, and preferred network pharmacy services. Mail-delivery involves the direct shipment of medications to a designated location through mail-order systems. These services are delivered across various types of PBM models, including commercial health plans, self-insured employer plans, Medicare Part D plans, and the Federal Employees Health Benefits Program. These PBM models serve key end users such as pharmacy benefit management organizations, mail-order pharmacies, retail pharmacies, inpatient pharmacies, and outpatient pharmacies.

The pharmacy benefit management market includes revenues earned by entities by providing case management, disease management, and drug utilization services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.